Matthias Leifgen

Jana Solomun

Jana Solomun graduated in Pharmacy from the Free University of Berlin, Germany, and subsequently worked in academic research in various scientific fields.

During her research stay at the Strathclyde Institute of Pharmacy & Biomedical Sciences in Glasgow, UK, she explored the application of natural proteins such as silk protein in nanomedicine. She then worked on her PhD at the Friedrich Schiller University in Jena, Germany, at the Institute of Organic Chemistry and Macromolecular Chemistry. In the course of her PhD, she focused on the development of functional polymer-based materials for gene transport and their biological characterization in vitro and in vivo. Her focus was on the development of stable polymer-DNA complexes, the physicochemical characterization of the complexes and the investigation of biological effects in eukaryotic cells. By conducting her PhD in an interdisciplinary DFG-funded collaborative research center, she also gained diverse insights into a wide range of topics in chemistry, pharmacy and medicine, such as polymer synthesis and the development of new anti-inflammatory agents.

Her research results have been published in numerous scientific papers in renowned journals (ACS Biomaterials - Science & Engineering, Nanoscale, Journal of Nanobiotechnology, International Journal of Pharmaceutics and others).

At Hertin, she is involved in evaluating invention disclosures and conducting searches, drafting patent applications and enforcing IP rights, and participating in opposition and appeal proceedings. Through her work in academic research and her studies, she can draw on extensive expertise in areas including pharmaceutical formulation, nanoparticle formulation and nanomedicine, diagnostic and gene therapy methods, materials science such as polymer chemistry, and drug development.

Matthias Leifgen